Antonio Passaro: Discussing EGFR-mutant Lung Cancer with Umberto Malapelle

Antonio Passaro shared a post on X:

“Always a pleasure, exciting, & inspiring to keep studying and discussing EGFR-mutant Lung Cancer with my dear friend Umberto, pushing ourselves to expand our knowledge and skills.

Raising the bar remains our goal, always striving to offer the best care for our patients.”

Antonio Passaro MD PhD, a medical oncologist at the European Institute of Oncology in Milan, specializes in lung cancer research and treatment. He focuses on developing new therapies, including immunotherapy, and identifying reliable biomarkers for non-small cell lung cancer (NSCLC). Dr. Antonio Passaro is an Associate Editor for Lung Cancer Journal by Elsevier and the Chair of the ESMO Press & Media Affairs Committee. He is also a faculty member for the Lung and Other Thoracic Tumours faculty group and the ESMO-MCBS Extended Working Group. He also holds editorial positions and key roles in societies like ESMO and AIOM.